Viewing nowTelcadin 20 mg Tablets (Telmisartan)
Telmisartan 20mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 202500867 · Approved 2025.04.14 · Insurance code 648105230
Treatment of essential hypertension; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is used to treat essential hypertension. Additionally, it helps reduce the risks of myocardial infarction, stroke, and mortality due to cardiovascular diseases in patients aged 55 and over with a high risk of cardiovascular events, such as those with a history of coronary artery disease, peripheral artery disease, stroke or transient ischemic attack, or those with diabetes that has caused damage to end organs. It can be safely administered to patients who cannot use ACE inhibitors. This drug improves cardiovascular health and contributes to the prevention of complications.
1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This drug has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally with water at a dose of 80 mg once daily, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medications may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This drug can cause serious harm to the fetus and newborn during pregnancy; therefore, use should be stopped immediately upon confirmation of pregnancy. Patients who are allergic to this drug or its components, pregnant or breastfeeding women, individuals with severe liver impairment or biliary obstruction, patients with hereditary angioedema, and those with certain kidney function impairments should not use this drug. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, patients with valvular heart disease or ischemic heart disease, gastrointestinal disorders, or those with renal vascular hypertension should use this drug with caution. While taking this drug, rare side effects such as hypotension, hyperkalemia, renal function impairment, angioedema, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur; immediate consultation with a healthcare provider is necessary if symptoms occur. Particularly, diabetic patients should be closely monitored for signs of hypoglycemia, as there may be risks of significantly low blood pressure, fainting, or loss of consciousness. It is safe to take this medication while regularly monitoring kidney function and serum potassium levels, and precautions should be taken in cases of volume depletion or sodium deficiency, as this may lead to hypotensive risks. Moreover, this drug may interact with other antihypertensives, specific diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is essential to inform the healthcare provider about any other medications being taken. Women planning or currently pregnant should avoid using this medication, and breastfeeding mothers should also refrain from taking it. This drug is not recommended for children and adolescents under 18 years of age, as safety and efficacy have not been established. In cases of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute renal failure may occur; immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children, and care should be taken as transferring it to another container may adversely affect its quality. Caution is needed while driving or operating hazardous machinery as there may be risks of fainting or dizziness.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is at room temperature between 1°C and 30°C, avoiding excessively hot or cold places.
White round tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 20mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.